Publicații și colaborări

O selecție de lucrări peer-reviewed la care au contribuit membri și parteneri ai Glia Institute, indexate în PubMed.

Activitate științifică și efort colectiv

Lucrări listate

2025–2026

Interval de publicare

100%

Acces deschis

NeuroimagisticăMachine learningAcces liber
Unsupervised Machine Learning of Automated Brain Volumetry Uncovers Three Volumetric Endophenotypes in Cognitive Impairment.
Vamanu A, Borza LR, Livinț-Popa L, Mastaleru A, Covali R, Bilcu RV, Socolov-Mihaita SA, Dima-Cozma LC, Cozma RS, Serban R, Olariu R, Patrascu A, Chihaia CA, Ciubotaru A.
Balneo and PRM Research Journal. 2026 Jul 10;17(2):1062.
Vezi articolul
Boala AlzheimerNeurologieReviewAcces liber
Pharmacological and Clinical Heterogeneity of Anti-Amyloid Monoclonal Antibodies in Early Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
Vamanu A, Mastaleru A, Schreiner TG, Popescu G, Roceanu AM, Cucu AI, Patrascu A, Vulpoi GA, Bilcu RV, Cozma RS, Olariu R, Bistriceanu CE, Covali R, Cuciureanu DI, Ciubotaru A.
Med Sci (Basel). 2026 Jun 23;14(3):337.
DOI: 10.3390/medsci14030337Vezi articolul
Scleroză multiplăNeurologieReviewAcces liber
Systematic Review of Monoclonal Antibody Therapies in Relapsing Multiple Sclerosis: Comparator-Stratified Analysis of Relapse and Disability Outcomes.
Ciubotaru A, Grosu C, Mаștaleru A, Constantinescu V, Alexa D, Covali R, Riscanu L, Bilcu RV, Cucu LE, Gațcan C, Socolov-Mihaita SA, Lăcătușu D, Crivoi F, Vamanu A, Patrascu A, Ignat EB.
Med Sci (Basel). 2026 Feb 27;14(1):116.
PMID: 41892831DOI: 10.3390/medsci14010116Vezi pe PubMed
BiomarkeriMachine learningAcces liber
Integrated Biomarker-Volumetric Profiling Defines Neurodegenerative Subtypes and Predicts Neuroaxonal Injury in Multiple Sclerosis Based on Bayesian and Machine Learning Analyses.
Ciubotaru A, Covali R, Grosu C, Alexa D, Riscanu L, Robert-Valentin B, Popa R, Sargu GD, Popa C, Filip C, Cucu LE, Vamanu A, Constantinescu V, Ignat EB.
Biomedicines. 2025 Dec 24;14(1):42.
PMID: 41595578DOI: 10.3390/biomedicines14010042Vezi pe PubMed
Neuropatie diabeticăNutriție clinicăReviewAcces liber
Alpha-Lipoic Acid and Benfotiamine in Diabetic Peripheral Neuropathy: A Critical Review of Mechanistic Rationale and Clinical Evidence Within a Nutritional Therapeutic Framework.
Ciubotaru A, Grosu C, Alexa D, Cucu LE, Schreiner TG, Bistriceanu CE, Mаștaleru A, Azoicāi D, Vamanu A, Patrascu A, Cuciureanu DI, Ignat EB.
Nutrients. 2026 May 12;18(10):1538.
PMID: 42196997DOI: 10.3390/nu18101538Vezi pe PubMed
Scleroză multiplăNeuroimagisticăAcces liber
Clinical Prediction of Functional Decline in Multiple Sclerosis Using Volumetry-Based Synthetic Brain Networks.
Ciubotaru A, Mаștaleru A, Schreiner TG, Filip C, Covali R, Riscanu L, Bilcu RV, Cucu LE, Socolov-Mihaita SA, Lăcătușu D, Crivoi F, Vamanu A, Martu I, Dima-Cozma LC, Cozma RS, Bitere-Popa OR.
Life (Basel). 2026 Mar 11;16(3):459.
PMID: 41900977DOI: 10.3390/life16030459Vezi pe PubMed

Sunteți cercetător sau clinician?

Trimiteți-ne publicațiile sau colaborările pe care doriți să le evidențiem aici.

Scrieți-ne

O selecție de lucrări peer-reviewed la care au contribuit membri și parteneri ai Glia Institute, indexate în PubMed.

Unsupervised Machine Learning of Automated Brain Volumetry Uncovers Three Volumetric Endophenotypes in Cognitive Impairment.

Pharmacological and Clinical Heterogeneity of Anti-Amyloid Monoclonal Antibodies in Early Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Trials.

Systematic Review of Monoclonal Antibody Therapies in Relapsing Multiple Sclerosis: Comparator-Stratified Analysis of Relapse and Disability Outcomes.

Integrated Biomarker-Volumetric Profiling Defines Neurodegenerative Subtypes and Predicts Neuroaxonal Injury in Multiple Sclerosis Based on Bayesian and Machine Learning Analyses.

Alpha-Lipoic Acid and Benfotiamine in Diabetic Peripheral Neuropathy: A Critical Review of Mechanistic Rationale and Clinical Evidence Within a Nutritional Therapeutic Framework.

Clinical Prediction of Functional Decline in Multiple Sclerosis Using Volumetry-Based Synthetic Brain Networks.

Sunteți cercetător sau clinician?

Glia Institute colaborează cu mândrie cu: